EP 3551634 A1 20191016 - SUBSTITUTED PYRAZOLOAZEPIN-8-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS
Title (en)
SUBSTITUTED PYRAZOLOAZEPIN-8-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS
Title (de)
SUBSTITUIERTE PYRAZOLOAZEPIN-8-ONE UND DEREN VERWENDUNG ALS PHOSPHODIESTERASE-INHIBITOREN
Title (fr)
PYRAZOLOAZÉPIN-8-ONES SUBSTITUÉES, ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE LA PHOSPHODIESTÉRASE
Publication
Application
Priority
EP 2016080550 W 20161212
Abstract (en)
[origin: WO2018108231A1] The present invention relates to novel pyrazoloazepin-8-ones with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.
IPC 8 full level
C07D 491/20 (2006.01); A61K 31/438 (2006.01); A61P 17/00 (2006.01)
CPC (source: EP RU US)
A61K 31/55 (2013.01 - RU); A61P 17/00 (2018.01 - EP); A61P 17/06 (2018.01 - EP); A61P 17/14 (2018.01 - EP); A61P 29/00 (2018.01 - EP); A61P 35/00 (2018.01 - EP); A61P 37/08 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07D 491/20 (2013.01 - EP RU US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2018108231 A1 20180621; CN 110099905 A 20190806; CN 110099905 B 20240614; DK 3551634 T3 20210614; EP 3551634 A1 20191016; EP 3551634 B1 20210331; ES 2874632 T3 20211105; JP 2020500921 A 20200116; JP 6850887 B2 20210331; RU 2019121681 A 20210112; RU 2019121681 A3 20210112; RU 2764273 C2 20220117; US 10793580 B2 20201006; US 2019330223 A1 20191031
DOCDB simple family (application)
EP 2016080550 W 20161212; CN 201680091501 A 20161212; DK 16819452 T 20161212; EP 16819452 A 20161212; ES 16819452 T 20161212; JP 2019531212 A 20161212; RU 2019121681 A 20161212; US 201616468429 A 20161212